vs
DAKTRONICS INC（DAKT）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
DAKTRONICS INC的季度营收约是再鼎医药的1.8倍（$229.3M vs $127.1M），再鼎医药同比增速更快（17.1% vs 10.0%），DAKTRONICS INC自由现金流更多（$14.0M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 16.0%）
达科电子是一家总部位于美国南达科他州布鲁金斯的企业，由两名南达科他州立大学教授于1968年创立，主营业务涵盖视频显示屏、记分牌、数字广告牌、动态信息标识、音响系统及相关产品的设计、生产、销售与服务。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
DAKT vs ZLAB — 直观对比
营收规模更大
DAKT
是对方的1.8倍
$127.1M
营收增速更快
ZLAB
高出7.1%
10.0%
自由现金流更多
DAKT
多$40.7M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
16.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $229.3M | $127.1M |
| 净利润 | $17.5M | — |
| 毛利率 | 27.0% | 51.0% |
| 营业利润率 | 9.4% | -54.6% |
| 净利率 | 7.6% | — |
| 营收同比 | 10.0% | 17.1% |
| 净利润同比 | -18.3% | — |
| 每股收益（稀释后） | $0.35 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAKTZLAB
| Q4 25 | $229.3M | $127.1M | ||
| Q3 25 | $219.0M | $115.4M | ||
| Q2 25 | $172.6M | $109.1M | ||
| Q1 25 | $149.5M | $105.7M | ||
| Q4 24 | $208.3M | $108.5M | ||
| Q3 24 | $226.1M | $101.8M | ||
| Q2 24 | $215.9M | $100.1M | ||
| Q1 24 | $170.3M | $87.1M |
净利润DAKTZLAB
| Q4 25 | $17.5M | — | ||
| Q3 25 | $16.5M | $-36.0M | ||
| Q2 25 | $-9.4M | $-40.7M | ||
| Q1 25 | $-17.2M | $-48.4M | ||
| Q4 24 | $21.4M | — | ||
| Q3 24 | $-4.9M | $-41.7M | ||
| Q2 24 | $2.5M | $-80.3M | ||
| Q1 24 | $10.7M | $-53.5M |
毛利率DAKTZLAB
| Q4 25 | 27.0% | 51.0% | ||
| Q3 25 | 29.7% | 59.5% | ||
| Q2 25 | 25.0% | 60.6% | ||
| Q1 25 | 24.6% | 63.6% | ||
| Q4 24 | 26.8% | 61.5% | ||
| Q3 24 | 26.4% | 64.1% | ||
| Q2 24 | 25.7% | 64.9% | ||
| Q1 24 | 24.5% | 61.4% |
营业利润率DAKTZLAB
| Q4 25 | 9.4% | -54.6% | ||
| Q3 25 | 10.6% | -42.3% | ||
| Q2 25 | -1.0% | -50.3% | ||
| Q1 25 | -2.4% | -53.3% | ||
| Q4 24 | 7.6% | -62.6% | ||
| Q3 24 | 10.0% | -66.6% | ||
| Q2 24 | 9.0% | -76.0% | ||
| Q1 24 | 4.7% | -80.7% |
净利率DAKTZLAB
| Q4 25 | 7.6% | — | ||
| Q3 25 | 7.5% | -31.2% | ||
| Q2 25 | -5.5% | -37.3% | ||
| Q1 25 | -11.5% | -45.8% | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | -2.2% | -40.9% | ||
| Q2 24 | 1.2% | -80.2% | ||
| Q1 24 | 6.3% | -61.4% |
每股收益（稀释后）DAKTZLAB
| Q4 25 | $0.35 | $-0.05 | ||
| Q3 25 | $0.33 | $-0.03 | ||
| Q2 25 | $0.04 | $-0.04 | ||
| Q1 25 | $-0.36 | $-0.04 | ||
| Q4 24 | $0.22 | $-0.09 | ||
| Q3 24 | $-0.11 | $-0.04 | ||
| Q2 24 | $0.18 | $-0.08 | ||
| Q1 24 | $0.09 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $149.6M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $297.5M | $715.5M |
| 总资产 | $548.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DAKTZLAB
| Q4 25 | $149.6M | $689.6M | ||
| Q3 25 | $136.9M | $717.2M | ||
| Q2 25 | $127.5M | $732.2M | ||
| Q1 25 | $132.2M | $757.3M | ||
| Q4 24 | $134.4M | $779.7M | ||
| Q3 24 | $96.8M | $616.1M | ||
| Q2 24 | $81.3M | $630.0M | ||
| Q1 24 | $76.8M | $650.8M |
股东权益DAKTZLAB
| Q4 25 | $297.5M | $715.5M | ||
| Q3 25 | $279.8M | $759.9M | ||
| Q2 25 | $271.9M | $791.7M | ||
| Q1 25 | $272.3M | $810.8M | ||
| Q4 24 | $260.9M | $840.9M | ||
| Q3 24 | $238.2M | $667.7M | ||
| Q2 24 | $238.8M | $704.2M | ||
| Q1 24 | $236.2M | $762.2M |
总资产DAKTZLAB
| Q4 25 | $548.4M | $1.2B | ||
| Q3 25 | $545.6M | $1.2B | ||
| Q2 25 | $502.9M | $1.2B | ||
| Q1 25 | $524.2M | $1.2B | ||
| Q4 24 | $551.9M | $1.2B | ||
| Q3 24 | $553.9M | $985.3M | ||
| Q2 24 | $527.9M | $987.4M | ||
| Q1 24 | $499.2M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.5M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $14.0M | $-26.7M |
| 自由现金流率自由现金流/营收 | 6.1% | -21.0% |
| 资本支出强度资本支出/营收 | 1.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.94× | — |
| 过去12个月自由现金流最近4个季度 | $61.7M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流DAKTZLAB
| Q4 25 | $16.5M | $-26.0M | ||
| Q3 25 | $26.1M | $-32.0M | ||
| Q2 25 | $22.9M | $-31.0M | ||
| Q1 25 | $12.0M | $-61.7M | ||
| Q4 24 | $43.3M | $-55.8M | ||
| Q3 24 | $19.5M | $-26.8M | ||
| Q2 24 | $9.5M | $-42.2M | ||
| Q1 24 | $9.5M | $-90.1M |
自由现金流DAKTZLAB
| Q4 25 | $14.0M | $-26.7M | ||
| Q3 25 | $21.8M | $-35.0M | ||
| Q2 25 | $18.0M | $-33.9M | ||
| Q1 25 | $7.8M | $-63.2M | ||
| Q4 24 | $38.0M | $-58.4M | ||
| Q3 24 | $14.4M | $-28.2M | ||
| Q2 24 | $6.1M | $-42.9M | ||
| Q1 24 | $5.1M | $-91.1M |
自由现金流率DAKTZLAB
| Q4 25 | 6.1% | -21.0% | ||
| Q3 25 | 10.0% | -30.4% | ||
| Q2 25 | 10.5% | -31.1% | ||
| Q1 25 | 5.2% | -59.9% | ||
| Q4 24 | 18.2% | -53.8% | ||
| Q3 24 | 6.4% | -27.7% | ||
| Q2 24 | 2.8% | -42.9% | ||
| Q1 24 | 3.0% | -104.5% |
资本支出强度DAKTZLAB
| Q4 25 | 1.1% | 0.5% | ||
| Q3 25 | 2.0% | 2.6% | ||
| Q2 25 | 2.8% | 2.6% | ||
| Q1 25 | 2.8% | 1.5% | ||
| Q4 24 | 2.6% | 2.4% | ||
| Q3 24 | 2.2% | 1.3% | ||
| Q2 24 | 1.6% | 0.7% | ||
| Q1 24 | 2.6% | 1.1% |
现金转化率DAKTZLAB
| Q4 25 | 0.94× | — | ||
| Q3 25 | 1.58× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.75× | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAKT
| Live Events Segment | $81.5M | 36% |
| Transferred At Point In Time | $41.9M | 18% |
| Limited Configuration | $39.2M | 17% |
| Other | $30.6M | 13% |
| Transportation Segment | $21.3M | 9% |
| Transferred Over Time | $8.8M | 4% |
| Unique Configuration | $6.0M | 3% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
